Analyst Recommendations
Barclays analyst issues OVERWEIGHT recommendation for CROX on April 1, 2024 04:29AM ET. The previous analyst recommendation was Outperform.CROX was trading at $143.8 at issue of the analyst...April 1, 2024 CROX 3.73%
Morgan Stanley analyst issues OVERWEIGHT recommendation for DAL on April 1, 2024 03:44AM ET. The previous analyst recommendation was Overweight.DAL was trading at $47.87 at issue of the...April 1, 2024 DAL 4.65%
Barclays analyst issues OVERWEIGHT recommendation for DECK on April 1, 2024 04:29AM ET. DECK was trading at $941.26 at issue of the analyst recommendation.The overall analyst consensus :...April 1, 2024 DECK 4.48%
Wolfe Research analyst issues OUTPERFORM recommendation for CW on April 1, 2024 03:38AM ET. The previous analyst recommendation was Outperform.CW was trading at $255.94 at issue of the...April 1, 2024 CW 0.04%
Wolfe Research analyst issues OUTPERFORM recommendation for EXC on April 1, 2024 03:38AM ET. The previous analyst recommendation was Outperform.EXC was trading at $37.57 at issue of the...April 1, 2024 EXC 0.75%
Jefferies analyst issues BUY recommendation for AU on April 1, 2024 03:33AM ET. The previous analyst recommendation was Buy.AU was trading at $22.2 at issue of the analyst...April 1, 2024 AU 0.85%
Wolfe Research analyst issues OUTPERFORM recommendation for GD on April 1, 2024 03:39AM ET. The previous analyst recommendation was Outperform.GD was trading at $282.49 at issue of the...April 1, 2024 GD 0.27%
Barclays analyst issues UNDERWEIGHT recommendation for CHRW on April 1, 2024 04:27AM ET. CHRW was trading at $76.14 at issue of the analyst recommendation.The overall analyst consensus :...April 1, 2024 CHRW 2.09%
Morgan Stanley analyst issues OVERWEIGHT recommendation for TT on April 1, 2024 03:37AM ET. The previous analyst recommendation was Underweight.TT was trading at $300.2 at issue of the...April 1, 2024 TT 2.51%
Goldman Sachs analyst issues BUY recommendation for CCJ on April 1, 2024 04:37AM ET. CCJ was trading at $43.32 at issue of the analyst recommendation.The overall analyst consensus...April 1, 2024 CCJ -3.10%
